GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » 14-Day RSI

Peterlabs Holdings Bhd (XKLS:0171) 14-Day RSI : 53.36 (As of Jun. 23, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Peterlabs Holdings Bhd 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-06-23), Peterlabs Holdings Bhd's 14-Day RSI is 53.36.

The industry rank for Peterlabs Holdings Bhd's 14-Day RSI or its related term are showing as below:

XKLS:0171's 14-Day RSI is ranked worse than
71.09% of 1145 companies
in the Drug Manufacturers industry
Industry Median: 45.94 vs XKLS:0171: 53.36

Competitive Comparison of Peterlabs Holdings Bhd's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's 14-Day RSI falls into.



Peterlabs Holdings Bhd  (XKLS:0171) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peterlabs Holdings Bhd  (XKLS:0171) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Peterlabs Holdings Bhd 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Peterlabs Holdings Bhd's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Peterlabs Holdings Bhd (XKLS:0171) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is a Malaysia based company engaged in manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis and feed formulation. The operating segments of the group are Manufacturing which relates to manufacturing of animal health and nutrition products, and Trading which relates to trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplement, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally, and generates key revenue from the Trading segment.

Peterlabs Holdings Bhd (XKLS:0171) Headlines

No Headlines